QURE 8-K 2026-09-29
uniQure N.V. (QURE) 8-K dated 2026-09-29 — accession 0001104659-26-111654.
uniQure N.V. (QURE) is a biotechnology company listed on NASDAQ.
uniQure N.V. filed a 8-K on 2026-09-29. Accession 0001104659-26-111654.
This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
Not investment advice. The QURE SEC hub lists recent forms. The stock page is the research view.